Endocrine Therapy NewsLatest News On Endocrine Therapy Balancing Benefit and Risk: Optimizing Systemic Therapies for HR+ Early-Stage Breast Cancer8/13/2025 12:56 PM Does Elinzanetant Reduce VMS in Younger Patients With HR+ Breast Cancer?6/27/2025 3:56 AM SGO 2025: Gaining Ground in the Treatment of Endometrial Cancer3/21/2025 2:24 PM Chemotherapy Linked to Long-Lasting Health Decline in Breast Cancer Survivors3/11/2025 4:09 AM Post-Pregnancy Endocrine Therapy Resumption Rates Fall Short in Real-World Oncology Practice2/13/2025 12:19 PM Radiotherapy May Offer Better Quality of Life for Older Women with Early Breast Cancer2/6/2025 4:10 AM Palbociclib Plus Anti-HER2 Therapy Shows Long Progression-Free Survival in HER2-Positive Metastatic Breast Cancer1/9/2025 1:09 AM Machine Learning Model Predicts Benefit of CDK4/6 Inhibitors in Metastatic Breast Cancer12/19/2024 6:37 AM Trastuzumab Deruxtecan Shows Promise for HR+/HER2-Low/Ultra-Low Metastatic Breast Cancer12/19/2024 4:55 AM Nab-Paclitaxel Improves Survival in HR+/HER2– Early Breast Cancer Patients with Low Recurrence Scores12/19/2024 3:11 AM
